S100A12 and COVID-19: ,65,66,67,68,69,70 Furthermore, two additional markers ApoA1 and S100A12, also showed diagnostic potential for COVID-19 confirming the earlier reported downregulation of ApoA1 and the upregulation of S100A12 in COVID-19 patients in France and China.71